Latest Vaccination Stories

GAITHERSBURG, Md., Nov. 14, 2012 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) announced today that data were presented on GenVec's malaria vaccine program at the American Society of Tropical Medicine and Hygiene (ASTMH) 61st Annual Meeting, which took take place in Atlanta, Georgia on November 11-15, 2012. Data presented at the conference highlighted GenVec's success in identifying novel antigens for use in its malarial vaccine development program. Using a proprietary...

BLUE BELL, Pa., Nov. 14, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) has expanded its existing license agreement with the University of Pennsylvania (UPenn), adding worldwide rights to technology and intellectual property for novel synthetic vaccines against cancer, infectious diseases and potential biodefense pathogens. These technologies were developed by UPenn Professor David B. Weiner and collaborators. Dr. Weiner is a pioneer in the field of DNA vaccines,...

RED BANK, N.J., and WHITEHOUSE STATION, N.J., Nov. 13, 2012 /PRNewswire/ -- Vaccines play an important part in helping to maintain health and wellness for people of all ages, not just children. Yet 58 percent of American adults admit that they are not aware of the vaccines that are recommended. In fact, the US Centers for Disease Control and Prevention (CDC) has vaccination schedules for preteens, teens and adults, in addition to children. That's why HealthyWomen, a leading...

Sexually-transmitted diseases (STDs) enter the body through the mucosal epithelial cells and the ability to direct pathogen-clearing T-cells to points of infection may be the critical element in developing successful vaccines against these infections. In a study published in the Journal of Clinical Investigation, researchers led by John Schiller at the National Cancer Institute investigated the immune response to intravaginal immunization in mice infected with a form of the HPV virus carrying...

Rapid mutation has long been considered a key to viral adaptation to environmental change. But in the case of the coronavirus responsible for deadly severe acute respiratory syndrome (SARS), collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations cripples the virus's ability to cause disease in animals. In addition, they say this finding may allow scientists to explore a new option for creating safer live...

WORCESTER, Mass. and TORONTO, Nov. 13, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB:GNBT) today provided the following update on company initiatives. Antigen Express, Inc. (www.antigenexpress.com), a wholly-owned subsidiary of Generex, is in late Phase II clinical development of a novel immunotherapeutic for breast cancer (AE37) that demonstrates promising trends in preventing relapse. The interim results of the large, controlled, randomized, and single blinded trial...

BLUE BELL, Pa., Nov. 12, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that its synthetic hepatitis B (HBV) therapeutic vaccine generated strong T cell responses that eliminated targeted liver cells in mice. This data points to the DNA vaccine's potential to clear HBV infection and thereby prevent liver cancer in humans, an encouraging development given that nearly one-third of the world's population is infected with hepatitis B, with 400 million...

redOrbit Staff & Wire Reports – Your Universe Online Less than one-third of newborns who received an experimental new vaccination against malaria were successfully protected from the potentially fatal disease, according to research presented Friday at a Vaccines for Africa conference in Cape Town, South Africa. According to AP Medical Writer Maria Cheng, the three-shot vaccine, which is produced by pharmaceutical company GlaxoSmithKline (GSK) and is being tested in seven African...

LAKELAND, Fla., Nov. 8, 2012 /PRNewswire-USNewswire/ -- With seven confirmed cases of rabies in wildlife across Polk County this year, an increase over two previous years, SPCA Florida is responding by providing 1,000 free rabies vaccinations for dogs and cats now through the end of the year through its Wellness Wagon mobile veterinary clinic. Dr. Nicole Ferguson, SPCA Florida Chief Shelter Veterinarian says, "Rabies is a zoonotic disease, one that is spread to humans by animals....

LANCASTER, Pa. and ROCKVILLE, Md., Nov. 8, 2012 /PRNewswire/ -- Immunomic Therapeutics, Inc., ("ITI," Lancaster, PA) a leader in developing novel allergy immunotherapies, announced today that it has dosed the first patient in a Phase I clinical trial of its lead candidate, JRC-LAMP-vax(TM) vaccine, at its clinical site in Honolulu, Hawaii. Initial subjects include Japanese ex-patriates previously exposed to Japanese red cedar, or "Sugi," as it is known in Japan. JRC-LAMP-vax vaccine...